Market News

4 min read | Updated on September 17, 2026, 13:04 IST
SUMMARY
The personal care company plans to utilise at least 75% of the maximum buyback size, amounting to ₹211.50 crore, for the buyback.
Stock list

The maximum buyback size represents 9.28% and 9.98% of Emami’s total paid-up capital and free reserves based on its audited consolidated financial statements of Q1 FY27. Image: Shutterstock
The board of directors approved a buyback of the company’s fully paid-up equity shares with a face value of ₹1 each for an aggregate amount of up to ₹282 crore, excluding applicable fees, taxes and other related expenses.
Emami in a regulatory filing said that the buyback will be carried out through the open market using the stock exchange mechanism at a maximum price of ₹475 per equity share. The company will buy back shares from shareholders and beneficial owners, excluding promoters, members of the promoter group and persons in control and their associates.
At the maximum buyback size and price of ₹475 per share, Emami is expected to buy back up to 59,36,842 equity shares, representing 1.36% of the firm’s existing paid-up equity share capital as of March 31, 2026, and approximately 1.36% as of the date of the board meeting.
“If the Equity Shares are bought back at a price below Maximum Buy Back Price, the actual number of Equity Shares bought back could exceed the Maximum Buyback Shares, but will always be subject to the Maximum Buy Back Size,” Emami said in a regulatory filing.
The personal care company plans to utilise at least 75% of the maximum buyback size, amounting to ₹211.50 crore, for the buyback. Based on the minimum buyback size and the maximum buyback price of ₹475 per share, Emami said it would purchase a minimum of 44,52,632 equity shares.
Further, the company will also utilise 40% of the maximum buyback size, or ₹112.80 crore, within the initial half of the buyback period from the opening of the offer.
The maximum buyback size represents 9.28% and 9.98% of Emami’s total paid-up capital and free reserves based on its audited consolidated financial statements as of March 31, 2026. The buyback size is within the 10% limit of the company’s total paid-up capital and free reserves, it said.
The board of directors have also set up a committee for the buyback. “The public announcement setting out the process, timelines and other statutory details of the Buyback will be released in due course, in accordance with the Buyback Regulations,” Emami said.
At 12:53 PM, Emami shares were trading at ₹383.65 apiece on the National Stock Exchange, rising 3.89%.
Over a month’s time, the stock has slipped 5%, while it has declined 8% in the past six months. From the beginning of the year, Emami shares have tumbled 27%.
Shares of the company had touched their one-year high of ₹614 apiece on September 18, 2025, while their 52-week low of ₹361.15 was hit on September 1, 2026.
Emami is a Kolkata-based FMCG company focused on personal care and healthcare products, with a portfolio that includes brands such as BoroPlus, Navratna, Zandu, Kesh King, Dermicool and Mentho Plus.
The company reported a turnover of ₹3,780 crore in FY26 and has more than 25 brands, with 10 brands generating annual revenue of over ₹100 crore.
It has a distribution network covering around 5.4 million outlets in India and a presence across more than 70 countries. Emami targets 25% turnover from strategic investments by FY30.
According to NSE data, as of September 17, 2026, Emami has a total market capitalisation of ₹16,739.78 crore.
Related News
About The Author

Next Story